Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

NCT04874142 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: YYC506-T
DRUG: YYC506-A
DRUG: YYC506-T + YYC506-A
DRUG: YYC506-A + YYC506-T

Sponsor

Yooyoung Pharmaceutical Co., Ltd.